Galaxy Medicare IPO is a book-built issue, aiming to raise ₹22.31 crore. It comprises a fresh issue of 0.33 crore equity shares aggregating to ₹17.86 crore and an offer for sale of 0.08 crore equity shares amounting to ₹4.45 crore. The bidding window was open from September 10, 2025, to September 12, 2025, with the IPO allotment to be finalised on September 15, 2025. Galaxy Medicare is scheduled to list on NSE SME on September 17, 2025.
The IPO was priced at ₹51-₹54 per share with a lot size of 2,000 shares. The public issue received bids for 71,90,000 shares against 39,24,000 shares available, resulting in an overall subscription of 1.83 times. Retail investors subscribed 2.10 times, NIIs 1.48 times, while QIBs subscribed 1.00 times their quota.
Galaxy Medicare’s ₹22.31 crore IPO, priced at ₹51-₹54 per share, was subscribed 1.83 times overall. The IPO is a fresh issue of 0.33 crore equity shares aggregating to ₹17.86 crore and an offer for sale of 0.08 crore equity shares amounting to ₹4.45 crore. Bidding took place from September 10 to September 12, 2025, with the Galaxy Medicare IPO allotment status on September 15, 2025. Retail investors subscribed 2.10 times and NIIs 1.48 times. Listing is expected on September 17, 2025.
The table below breaks down the Galaxy Medicare share allocation for different categories, highlighting the number of shares and their percentage of the total issue. However, the key focus remains on the quotas allocated to retail investors and HNIs, as they are the most relevant for individual investors.
| Investor Category | Shares Offered |
| Market Maker Shares Offered | 2,08,000 (5.03%) |
| QIB Shares Offered | 80,000 (1.94%) |
| NII (HNI) Shares Offered | 15,36,000 (37.17%) |
| − bNII > ₹10L | 10,24,000 (24.78%) |
| − sNII < ₹10L | 5,12,000 (12.39%) |
| Retail Shares Offered | 23,08,000 (55.86%) |
| Total Shares Offered | 41,32,000 (100.00%) |
Data Source: NSE
| Category | Subscription (times) |
| Qualified Institutional Buyers | 1 |
| Non-Institutional Investors | 1.48 |
| Retail Individual Investors | 2.1 |
| Total | 1.83 |
Note: The subscription details are as of September 12, 2025
Galaxy Medicare Limited was incorporated in July 1992 and is engaged in the manufacturing and export of medical devices, POP bandages, adhesive tapes, and surgical dressings. Its products include gauze products, compression bandages, wound care solutions, and orthopaedic support items, catering to diverse healthcare needs.
The company markets flagship brands such as POP BAND, G CAST, CARETAPE, CAREPORE, and FIXCAN, while also providing OEM services to brand owners under a Principal-to-Principal model. In addition, Galaxy Medicare participates in institutional sales through government tenders on the GEM Portal, further strengthening its domestic presence.
Exports are a key part of the company’s business model, with products shipped to international markets alongside domestic distribution to government health departments, corporate hospitals, and private entities. With 27 registered trademarks in India, Galaxy Medicare has developed a strong brand portfolio that is recognised in the medical community.
The company holds ISO 9001:2015 and ISO 13485:2016 certifications, ensuring high-quality standards across its product line. As of March 2025, the company employed 190 people across its operations, supported by in-house quality assurance, research and development, and a robust manufacturing facility in Bhubaneshwar, Odisha.
Know more about IPO allotment status and check your application details online for the latest updates on share allocation.
Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.
Investments in the securities market are subject to market risks, read all the related documents carefully before investing.
Published on: Sep 12, 2025, 9:12 PM IST
Akshay Shivalkar
Akshay Shivalkar is a financial content specialist who strategises and creates SEO-optimised content on the stock market, mutual funds, and other investment products. With experience in fintech and mutual funds, he simplifies complex financial concepts to help investors make informed decisions through his writing.
Know MoreWe're Live on WhatsApp! Join our channel for market insights & updates
Get the link to download the App
